Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy
Junwei Yang, … , Kari Nejak, Youhua Liu
Junwei Yang, … , Kari Nejak, Youhua Liu
Published November 15, 2002
Citation Information: J Clin Invest. 2002;110(10):1525-1538. https://doi.org/10.1172/JCI16219.
View: Text | PDF
Article Nephrology

Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy

  • Text
  • PDF
Abstract

Research Article

Authors

Junwei Yang, Ryan W. Shultz, Wendy M. Mars, Rodney E. Wegner, Yingjian Li, Chunsun Dai, Kari Nejak, Youhua Liu

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
Deficiency of tPA selectively blocks the tubular epithelial-to-myofibrob...
Deficiency of tPA selectively blocks the tubular epithelial-to-myofibroblast transition but not myofibroblastic activation from interstitial fibroblasts. Immunofluorescence staining demonstrates α-SMA–positive myofibroblasts in the obstructed kidneys in tPA+/+ and tPA–/– mice. Left column: staining with α-SMA (red); middle column: staining with renal proximal tubule marker, fluorescein-conjugated lectin from T. purpureas (green); right column: merging of the two images. (a, b, and c) Images taken 3 days after UUO in tPA+/+ mice. (d, e, and f) Images taken 3 days after UUO in tPA–/– mice. (g, h, and i) Images taken 7 days after UUO in tPA+/+ mice. (j, k, and l) Images taken 7 days after UUO in tPA–/– mice. No significant difference in the intensity and localization of α-SMA–positive cells in the obstructed kidneys at day 3 after UUO was observed between tPA+/+ and tPA–/– mice. Marked tubular epithelial-to-myofibroblast transition was evident in tPA+/+ mice at 7 days after ureteral obstruction, as demonstrated by colocalization of α-SMA and tubular marker (yellow) (i). Myofibroblasts were reduced in number and limited to the interstitial compartment of the obstructed kidneys after 7 days in tPA–/– mice (l). Scale bar, 20 μm.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts